These findings were in line with those of Lo Sasso et al. [14], thus corroborating the critical role of intestinal-specific LXRα activation in regulating lipid and cholesterol homeostasis without producing side effects, such as liver steatosis and increased fatty acid synthesis. The gene discussed is NR1H3; the disease is fatty liver disease.